Evaluation of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent Low Risk Del(5q) MDS Patients. Final Results of Sintra-REV Phase III International Multicenter Clinical Tri... von López Cadenas, Félix, Lumbreras, Eva, González, Teresa, Xicoy, Blanca, Sánchez-García, Joaquín, Coll, Rosa, Slama, Bohrane, Hernández-Rivas, José Ángel, Thepot, Sylvain, Bernal, Teresa, Guerci-Bresler, Agnès, Sanz, Guillermo, Bargay, Joan, Amigo, Maria Luz, De Paz Arias, Raquel, Preudhomme, Claude, Giagounidis, Aristoteles, Platzbecker, Uwe, Wickenhauser, Stefan, Goetze, Katharina S., Arar, Ali, Hernández Rivas, Jesús M, Toribio Castelló, Sofía M, Fenaux, Pierre, Del Cañizo, Consuelo, Diez-Campelo, Maria

Volltext

Long-Term Evolution of Somatic Mutations in Patients with Del(5q) MDS Early Treated with Lenalidomide in the Sintra-Rev Clinical Trial: Safe and Effecitive Approach? von Toribio Castelló, Sofía M, Lopez-Cadenas, Felix, Preudhomme, Claude, Villaverde Ramiro, Angela, Fenwarth, Laurène, Lumbreras, Eva, González, Teresa, Del Rey, Mónica, Xicoy, Blanca, Renneville, Aline, Sánchez-Garcia, Joaquín, Coll, Rosa, Slama, Bohrane, Hernández-Rivas, José Ángel, Thepot, Sylvain, Bernal, Teresa, Guerci-Bresler, Agnès, Götze, Katharina, Hernández-Rivas, Jesús María, Fenaux, Pierre, Del Cañizo, Consuelo, Diez-Campelo, Maria

Volltext